Raising external financing from a financial investor
Capital One Advisers, acting as a financial adviser, advised SDS Optic on the comprehensive preparation and capital raising from a professional investment fund supporting the development of innovative enterprises.
SDS Optic has developed a globally unique innovative technology for diagnosing and monitoring the condition of living tissue in vivo (in the patient’s body) and is developing a dedicated diagnostic device including a diagnostic microprobe and a detector of biologically active compounds. The company, which previously specialized in optoelectronics and biotechnology applications, has been conducting research and development work since 2015 on the development of an innovative microprobe technology – an invention based on the combined expertise of biochemistry as well as fiber-optic and laser engineering scientists. Applications of the microprobe are expected to include diagnostics (including cancer) and monitoring of the effectiveness of therapies (e.g., cancer targeted therapies), in real time and in a natural state, using methods that were not available previously. SDS Optic strategically intends to focus on helping the medical world diagnose diseases faster, in a less painful and less invasive way, and support rapid, effective treatment using targeted therapies, especially in the area of cancer.
The financial investor involved in the transaction is a professional investment fund that supports the growth of innovative companies at the early stage of development.
Service: Raising capital and investors
Client:
SDS OPTIC S.A.
Web address:
sdsoptic.comTransaction type:
CAPITAL ACQUISITION, ADVISORY SERVICES
CAPITAL ONE ADVISERS IN NUMBERS
COMPLETED
TRANSACTIONS
82
TOTAL VALUE
OF TRANSACTIONS
2.65
BILLION ZLOTYS
COMPANIES TAKEN
PUBLIC
34
OUR
EXPERIENCE
24
YEARS
LICENSES AND PARTNERSHIPS
Pandea Global M&A
WSE Partner
for SME
Authorized NewConnect
Adviser 2007–2026
Authorized Catalyst
Adviser 2009–2026
Polish Private Equity
and Venture Capital Association